Pharma major Novartis on Saturday announced that its drug Lutathera has shown significantly improved patient outcomes for gastroenteropancreatic neuroendocrine tumors....
trial
Patient characteristics for the pilot cRCTEnrolment across the baseline, intervention and ecology study periods are shown in Fig. 1.Figure 1Patients were...